Literature DB >> 9184863

Cystic dilatations of the common bile duct in adults.

G Kouraklis1, E Misiakos, A Glinavou, G Karatzas, J Gogas, G Skalkeas.   

Abstract

Cystic dilatations of the common bile duct are believed to be of congenital etiology with most cases presenting in childhood. During the last 20 years, 10 patients with cystic dilatations of the bile duct were treated in our Department. There were 5 men and 5 women with an age range of 35-81 years. Clinical presentation consisted of right hypohondrial pain, nausea, vomiting and a history of obstructive jaundice. Diagnosis was established by ultrasound, cholangiography and ERCP in most cases. According to the Todani classification system, 5 patients had type I cysts, 4 had type II and one had type III. At the time of surgery, main associated diseases were choledocholithiasis in 3 cases and cholangitis in 2 cases. One patient (type III) underwent endoscopic sphincterotomy; 4 patients underwent internal drainage and 2 of them developed mild cholangitis postoperatively; 5 patients underwent excision of the cyst and a biliary-enteric bypass and developed no main complications. Patients remained in good health during long-term follow-up. We conclude that cyst excision is the treatment of choice for adults in order to reduce postoperative morbidity and the potential risk of malignancy.

Entities:  

Mesh:

Year:  1996        PMID: 9184863      PMCID: PMC2423837          DOI: 10.1155/1996/28924

Source DB:  PubMed          Journal:  HPB Surg        ISSN: 0894-8569


  2 in total

1.  Experience of congenital choledochal cyst in adults:treatment, surgical procedures and clinical outcome in the Second Affiliated Hospital of Harbin Medical University.

Authors:  Long-Xian Zheng; Hong-Bo Jia; De-Quan Wu; Hong Shang; Xiang-Yu Zhong; Qiu-Shi Wang; Wen-Xue Zhou; Zhen-Hua Sun
Journal:  J Korean Med Sci       Date:  2004-12       Impact factor: 2.153

Review 2.  Biliary cysts: etiology, diagnosis and management.

Authors:  Beata Jabłońska
Journal:  World J Gastroenterol       Date:  2012-09-21       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.